This HTML5 document contains 55 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1093/JNCI/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q70649453
rdf:type
wikibase:Item
schema:description
article scientifique publié en 1993 wetenschappelijk artikel im April 1993 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована у квітні 1993 scientific article published on 01 April 1993 artículu científicu espublizáu n'abril de 1993
p:P577
wds:Q70649453-FF6EBDA4-AD01-4977-B88E-77CB4F275969
wdt:P577
1993-04-01T00:00:00Z
p:P407
wds:Q70649453-E1B9A13D-A2EA-43FD-BA86-8FC331CB678B
wdt:P407
wd:Q1860
p:P2093
wds:Q70649453-00B697C3-F68B-4B95-88F9-4264BA2AE4BD wds:Q70649453-4FF8C81B-7C23-4343-B7EF-4076D5F091E6 wds:Q70649453-3F420B9F-EAAA-46D5-9659-AE223C843987 wds:Q70649453-47D51064-6CC6-4E35-8BCD-9931A8A465E5 wds:Q70649453-1006B732-6A20-4192-A70B-FCB97BC6BCB9 wds:Q70649453-B07C13FB-2D10-4C09-9B15-A4975CB581D3 wds:Q70649453-BDEEB0AF-4C90-4FF0-944F-090DFF502704 wds:Q70649453-933365B1-6847-49FF-918A-F3FDFFF8604B wds:Q70649453-97DDB937-2BD2-4DA3-9555-2ADBC7743F0C wds:Q70649453-FD2CE13F-1E64-409F-89C0-BEA429960980
wdt:P2093
S Leitman M T Lotze D J Schwartzentruber J C Yang W M Linehan S L Topalian P Aebersold S A Rosenberg C A Seipp A E Chang
rdfs:label
Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer
skos:prefLabel
Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer
schema:name
Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer
p:P1476
wds:Q70649453-8907E856-A96F-44F7-930D-FD0214EEBE51
wdt:P1476
Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer
p:P304
wds:Q70649453-E5D6F3C7-98DA-4EFD-A705-C2B0EB02F4AD
wdt:P304
622-632
p:P31
wds:Q70649453-55CA744E-9030-4505-82CF-AFB90063EE5A
wdt:P31
wd:Q13442814
p:P698
wds:Q70649453-31697099-9F7E-4D23-83BE-EA84635EE256
wdtn:P698
n7:8468720
wdt:P698
8468720
p:P1433
wds:Q70649453-167DEC5D-9B51-4594-B4DF-1DB22784C194
wdt:P1433
wd:Q400279
p:P433
wds:Q70649453-28136938-5745-4A99-B079-7DD514675E50
p:P478
wds:Q70649453-707C3B48-9006-4E32-8620-9EB903A4BE8B
wdt:P433
8
wdt:P478
85
p:P356
wds:Q70649453-DA894653-BDF1-4C21-B229-5861D159A015
wdtn:P356
n11:85.8.622
wdt:P356
10.1093/JNCI/85.8.622